These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10376038)

  • 21. Herpes labialis.
    Worrall G
    Clin Evid; 2004 Dec; (12):2312-20. PubMed ID: 15865790
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of the efficacy and safety of a CS20® protective barrier gel containing OGT compared with topical aciclovir and placebo on functional and objective symptoms of labial herpes recurrences: a randomized clinical trial.
    Khemis A; Duteil L; Coudert AC; Tillet Y; Dereure O; Ortonne JP
    J Eur Acad Dermatol Venereol; 2012 Oct; 26(10):1240-6. PubMed ID: 21981375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Herpes labialis.
    Worrall G
    Clin Evid; 2004 Jun; (11):2174-81. PubMed ID: 15652107
    [No Abstract]   [Full Text] [Related]  

  • 24. Topical acyclovir is beneficial in recurrent herpes labialis.
    Lamey PJ
    BMJ; 1996 Apr; 312(7036):975. PubMed ID: 8616328
    [No Abstract]   [Full Text] [Related]  

  • 25. Herpes labialis.
    Worrall G
    Clin Evid; 2005 Dec; (14):2050-7. PubMed ID: 16620481
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of four antiviral agents in the treatment of uncomplicated herpetic keratitis.
    Panda A; Das GK; Khokhar S; Rao V
    Can J Ophthalmol; 1995 Aug; 30(5):256-8. PubMed ID: 8529160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antiviral therapy in herpetic keratitis].
    Popa DP; Ivaşcu M; Ristea L
    Oftalmologia; 1994; 38(2):159-61. PubMed ID: 8186212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial.
    Lin L; Chen XS; Cui PG; Wang JB; Guo ZP; Lu NZ; Bi ZG; Jia H; Yang XY;
    J Dermatolog Treat; 2002 Jun; 13(2):67-72. PubMed ID: 12060504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acyclovir for prevention of recurrent Herpes labialis?].
    Färber I
    Med Monatsschr Pharm; 2008 Jun; 31(6):226. PubMed ID: 18661914
    [No Abstract]   [Full Text] [Related]  

  • 30. Evidence for efficacy of topical acyclovir in recurrent herpes labialis is weak.
    Worrall G
    BMJ; 1996 Jul; 313(7048):46. PubMed ID: 8664786
    [No Abstract]   [Full Text] [Related]  

  • 31. [The Chameleon of Herpetic Keratitis - Diagnosis and Therapy].
    Seitz B; Heiligenhaus A
    Klin Monbl Augenheilkd; 2015 Jun; 232(6):745-53. PubMed ID: 26084963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent approval of Xerese in Canada: 5% acyclovir and 1% hydrocortisone topical cream in the treatment of herpes labialis.
    Nguyen HP; Stiegel KR; Downing C; Stiegel KR
    Skin Therapy Lett; 2014; 19(3):5-8. PubMed ID: 25188362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kanuka honey versus aciclovir for the topical treatment of herpes simplex labialis: a randomised controlled trial.
    Semprini A; Singer J; Braithwaite I; Shortt N; Thayabaran D; McConnell M; Weatherall M; Beasley R
    BMJ Open; 2019 May; 9(5):e026201. PubMed ID: 31092654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penciclovir for the treatment of herpes simplex labialis: a review.
    Randolph B
    ASDC J Dent Child; 2001; 68(3):189-90. PubMed ID: 11693011
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy and safety of aciclovir mucoadhesive buccal tablet in immunocompetent patients with labial herpes (LIP Trial): a double-blind, placebo-controlled, self-initiated trial.
    Bieber T; Chosidow O; Bodsworth N; Tyring S; Hercogova J; Bloch M; Davis M; Lewis M; Boutolleau D; Attali P;
    J Drugs Dermatol; 2014 Jul; 13(7):791-8. PubMed ID: 25007361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of acyclovir-resistant herpes simplex virus keratitis in a patient with Wiskott-Aldrich syndrome.
    Pratuangtham S; Bornstein SM; Boyer KM; McAuley JB; Deutsch TA; Gotoff SP
    Clin Infect Dis; 1997 Nov; 25(5):1257-8. PubMed ID: 9402402
    [No Abstract]   [Full Text] [Related]  

  • 37. When is systemic antiviral therapy indicated?
    Chou S
    Int J Dermatol; 1983; 22(1):19-21. PubMed ID: 6299984
    [No Abstract]   [Full Text] [Related]  

  • 38. [Herpes simplex keratitis following laser in situ keratomileusis].
    Gómez García S; Piñero Bustamante AM; Gutiérrez Sánchez E; Piñero Bustamante A
    Arch Soc Esp Oftalmol; 2004 Mar; 79(3):139-41. PubMed ID: 15045657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antiviral and non-antiviral general treatments for oro-facial and genital herpes (pregnancy and neonates excluded)].
    Guillaume JC
    Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):625-34. PubMed ID: 12122333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistant herpes simplex keratitis.
    Laibson PR
    Clin Exp Ophthalmol; 2010 Apr; 38(3):227-8. PubMed ID: 20447115
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.